Business Trends Impacting the Health Care Marketplace

[B8] Budgeting for the 2021 Specialty Drug Spend

ACPE UAN: 0233-0000-19-052-L04-P | Contact Hours: 1.25 | Activity Type: Knowledge-based

Faculty(s)

• 

  Susan Trieu, PharmD

  Director, Enterprise Specialty Clinical Solutions
  MedImpact Healthcare Systems, Inc.
  Southlake, Texas

Moderator(s)

• LV

  Lisa Valaika

  National Account Executive
  Takeda Oncology
  Long Beach, California

Join this session to become better prepared for upcoming changes in your specialty drug spend. Faculty will discuss specialty pharmaceuticals in the pipeline, their likely place in therapy, strategies for formulary management, and the products’ expected budget impact, all with a focus on the most high-impact specialty agents.

Learning Objectives:

At the completion of this activity, participants should be able to:

1. Identify high-impact specialty drugs in the 2020-2021 pipeline.
2. Summarize efficacy and safety data for high-impact pipeline drugs.
3. Explain how emerging pipeline drugs compare with currently available therapeutic options.
4. Indicate the likely place in therapy and budgetary impact of emerging pipeline drugs.